Hsbc Holdings PLC Sells 70,825 Shares of The Clorox Company $CLX

by · The Cerbat Gem

Hsbc Holdings PLC lowered its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 6.5% during the second quarter, HoldingsChannel.com reports. The fund owned 1,014,836 shares of the company’s stock after selling 70,825 shares during the quarter. Hsbc Holdings PLC’s holdings in Clorox were worth $121,599,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of CLX. Nomura Asset Management Co. Ltd. grew its position in shares of Clorox by 9.0% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after buying an additional 27,639 shares during the period. Simplicity Wealth LLC lifted its position in shares of Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,198 shares during the period. Raymond James Financial Inc. boosted its stake in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after acquiring an additional 36,352 shares in the last quarter. Vise Technologies Inc. acquired a new stake in Clorox in the second quarter worth $328,000. Finally, Nuance Investments LLC increased its stake in Clorox by 182.5% in the second quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock valued at $101,832,000 after purchasing an additional 547,839 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of NYSE:CLX opened at $107.32 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $13.09 billion, a PE ratio of 16.46, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52. The stock’s fifty day simple moving average is $113.61 and its two-hundred day simple moving average is $121.36. The Clorox Company has a 1-year low of $98.20 and a 1-year high of $171.37.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the company posted $1.86 earnings per share. The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Wednesday, January 28th. Clorox’s payout ratio is presently 77.86%.

Analyst Ratings Changes

CLX has been the topic of several research reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. UBS Group set a $119.00 price target on Clorox and gave the stock a “neutral” rating in a research note on Tuesday, November 4th. Jefferies Financial Group reiterated a “buy” rating and issued a $152.00 price target on shares of Clorox in a report on Tuesday, November 4th. Rothschild & Co Redburn reduced their price objective on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Finally, Morgan Stanley decreased their price objective on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $125.69.

Check Out Our Latest Analysis on Clorox

Insider Buying and Selling

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.63% of the stock is owned by insiders.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).